Bill is Director of Investments for the Kraft Group LLC. Since joining the Kraft Group in 1992, he has been involved with a number of investing and operating initiatives, including the creation of a dedicated family investment office which he now leads today. Bill also serves as Board Member or Observer at Elminda Ltd., Spero Therapeutics and Silk Therapeutics, and was a Board Member at Acetylon Pharmaceuticals. Bill received a B.S.B.A. from Northeastern University and a M.S.I.M. from Boston University.